Status:
COMPLETED
Prevalence of Gynecological Pathologies and Use of Hormonal Treatments in Women Hospitalized for a Venous Thromboembolic Episode
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
Venous Thromboembolism
Eligibility:
FEMALE
18-50 years
Brief Summary
The incidence of venous thrombosis (venous thromboembolic disease: VTE) in women of childbearing age in France is in the order of 0.3 to 0.5 / 1000 women / year. It is a rare disease, but the majority...
Detailed Description
Certain frequent gynecological pathologies are emerging in the literature as new venous thrombotic risk factors independently of hormonal treatment. Indeed, in endometriosis, the prevalence of which i...
Eligibility Criteria
Inclusion
- Women aged 18 to 50 years hospitalized at Saint Joseph Hospital between 01/01/2016 and 12/31/2020 for VTE
- ICD-10 codes I26, I80, I82, O22.3, O22.5.
Exclusion
- Patient under guardianship or curatorship
- Patient deprived of liberty
- Patient under court protection
- Patient objecting to the use of his or her data for this research.
Key Trial Info
Start Date :
June 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
201 Patients enrolled
Trial Details
Trial ID
NCT04920487
Start Date
June 5 2021
End Date
December 31 2022
Last Update
March 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, France, 75014